UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
dc.contributor.author | Deb, Shoumitro | |
dc.contributor.author | Nancarrow, T | |
dc.contributor.author | Limbu, B | |
dc.contributor.author | Sheehan, Rory | |
dc.contributor.author | Wilcock, M | |
dc.contributor.author | Branford, D | |
dc.contributor.author | Courtenay, K | |
dc.contributor.author | Perera, B | |
dc.contributor.author | Shankar, Rohit | |
dc.date.accessioned | 2021-05-22T19:14:43Z | |
dc.date.available | 2021-05-22T19:14:43Z | |
dc.date.issued | 2020-09 | |
dc.identifier.issn | 2056-4724 | |
dc.identifier.issn | 2056-4724 | |
dc.identifier.other | e112 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17178 | |
dc.description.abstract |
<jats:sec id="S2056472420000976_sec_a1" sec-type="other"> <jats:title>Background</jats:title> <jats:p>A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, ‘Stopping over-medication of people with a learning disability [intellectual disability], autism or both’ (STOMP), to address this major public health concern.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a2" sec-type="other"> <jats:title>Aims</jats:title> <jats:p>To gain understanding from UK psychiatrists working with adults with intellectual disabilities on the successes and challenges of withdrawing antipsychotics for challenging behaviours.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a3" sec-type="methods"> <jats:title>Method</jats:title> <jats:p>An online questionnaire was sent to all UK psychiatrists working in the field of intellectual disability (estimated 225).</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a4" sec-type="results"> <jats:title>Results</jats:title> <jats:p>Half of the 88 respondents stated that they started withdrawing antipsychotics over 5 years ago and 52.3% stated that they are less likely to initiate an antipsychotic since the launch of STOMP. However, since then, 46.6% are prescribing other classes of psychotropic medication instead of antipsychotics for challenging behaviours, most frequently the antidepressants. Complete antipsychotic discontinuation in over 50% of patients treated with antipsychotics was achieved by only 4.5% of respondents (<jats:italic>n</jats:italic> = 4); 11.4% reported deterioration in challenging behaviours in over 50% of patients on withdrawal and the same proportion (11.4%) reported no deterioration. Only 32% of respondents made the diagnosis of psychiatric illness in all their patients themselves. Family and paid carers’ concern, lack of multi-agency and multidisciplinary input and unavailability of non-medical psychosocial intervention are key reported factors hampering the withdrawal attempt.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a5" sec-type="conclusions"> <jats:title>Conclusions</jats:title> <jats:p>There is an urgent need to develop national guidelines to provide a framework for systematic psychotropic drug reviews and withdrawal where possible.</jats:p> </jats:sec> | |
dc.format.extent | e112- | |
dc.format.medium | Electronic | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | Royal College of Psychiatrists | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Intellectual disabilities | |
dc.subject | antipsychotics | |
dc.subject | withdrawal | |
dc.subject | adults | |
dc.subject | STOMP | |
dc.title | UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism | |
dc.type | journal-article | |
dc.type | Journal Article | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000570177800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 5 | |
plymouth.volume | 6 | |
plymouth.publication-status | Published | |
plymouth.journal | BJPsych Open | |
dc.identifier.doi | 10.1192/bjo.2020.97 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Users by role | |
dc.publisher.place | England | |
dc.identifier.eissn | 2056-4724 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1192/bjo.2020.97 | |
rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
rioxxterms.type | Journal Article/Review |